Trinity BiotechTRIB +17.06%25 Days Inventory is 236.70 as of Dec. 2025, which is 12% above its 10-year median of 210.59. GuruFocus rates TRIB with a GF Score™ of 25/100 and a GF Value™ of $0.73 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Trinity Biotech ranks worse than 71.76% on this metric.
The historical rank and industry rank for Trinity Biotech's Days Inventory or its related term are showing as below:
TRIB'
s Days Inventory Range Over the Past 10 Years
Min: 178.83 Med: 210.59 Max: 263.85
Current: 263.85
During the past 13 years, Trinity Biotech's highest Days Inventory was 263.85. The lowest was 178.83. And the median was 210.59.
TRIB's Days Inventory is ranked worse than 71.76% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs TRIB: 263.85
Trinity Biotech's Days Inventory
increased
from Dec. 2024 (185.50) to Dec. 2025 (236.70).
It might indicate that Trinity Biotech's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Trinity Biotech's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.77.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Trinity Biotech's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.77.
Trinity Biotech (NAS:TRIB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Trinity Biotech's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Trinity Biotech's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Trinity Biotech Days Inventory Related Terms
Trinity Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Trinity Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TRIB vs AIDX, NVNO, STME: Days Inventory Comparison
For the Medical Devices subindustry, Trinity Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trinity Biotech Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Trinity Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Trinity Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trinity Biotech (TRIB) has a Days Inventory of 236.70 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Trinity Biotech and its competitors. This is 12% above median its historical median of 210.59. Over the past decade, Trinity Biotech's Days Inventory has ranged from 178.83 to 263.85. According to the industry distribution chart, Trinity Biotech ranks #564 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 71.8%.
Is Trinity Biotech's Days Inventory too high?
Trinity Biotech's current Days Inventory of 236.70 is 12% above median its 10-year median of 210.59. Over the past 10 years, this metric has ranged from a low of 178.83 to a high of 263.85. The Medical Devices & Instruments industry median Days Inventory is 179.60. Trinity Biotech's value of 236.70 is 31.8% above this industry median. Based on the distribution chart, Trinity Biotech ranks #564 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Trinity Biotech has a GF Score™ of 25/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trinity Biotech's Days Inventory compare to AIDX and NVNO?
According to the Medical Devices & Instruments industry distribution chart, Trinity Biotech ranks #564 out of 786 companies for Days Inventory. This places Trinity Biotech in the lower half of its industry. The industry median Days Inventory is 179.60. Trinity Biotech's value of 236.70 is 31.8% above this benchmark. Historically, Trinity Biotech's own Days Inventory has ranged from 178.83 to 263.85 over the past decade. While the company's 10-year median is 210.59 vs. the industry median of 179.60, Trinity Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trinity Biotech's current Days Inventory of 236.70 is 31.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Trinity Biotech and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trinity Biotech's current Days Inventory is 236.70, which is 12% above median its own 10-year median of 210.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trinity Biotech stock overvalued right now?
Based on GuruFocus' analysis, Trinity Biotech (TRIB) is currently considered Possible Value Trap. The stock's GF Value™ is $0.73, compared to a current price of $0.42 — trading 42.8% below its estimated fair value. The current Days Inventory is 236.70, which is 12% above median its 10-year median of 210.59 and 31.8% above the Medical Devices & Instruments industry median of 179.60. Trinity Biotech's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Trinity Biotech (TRIB), the current Days Inventory is 236.70 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trinity Biotech (TRIB) Overvalued in 2026?
Based on GuruFocus' analysis, Trinity Biotech stock appears to be undervalued.
The current stock price of $0.42 is trading 42.8% below its estimated GF Value™ of $0.73.
GuruFocus considers Trinity Biotech to be Possible Value Trap.
Key valuation signals for TRIB:
Days Inventory: 236.70 (12% above median its 10-year median of 210.59)
GF Value™: $0.73 vs. price of $0.42 (42.8% below fair value)
Industry Position: 31.8% above the Medical Devices & Instruments median (#564 of 786)
No single metric tells the full story. See the TRIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
25GF Score
Get the complete analysis for TRIB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRIB has been successfully added to your 
